{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:52:41Z","timestamp":1782762761058,"version":"3.54.5"},"reference-count":51,"publisher":"American Association for Cancer Research (AACR)","issue":"10","funder":[{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["R01 CA181683-01A1"],"award-info":[{"award-number":["R01 CA181683-01A1"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Purpose: Tumor cell\u2013platelet interactions contribute to tumor progression and metastasis in solid tumors. However, the role of platelets in hematological malignancies is not clear. We investigated the association of platelet activation status with clinical stages in multiple myeloma (MM) patients and explored the role of platelets in MM progression.<\/jats:p>\n                  <jats:p>Experimental Design: Platelets were obtained from healthy donors and MM patients. We examined platelet activation status in MM patients by flow cytometry and transmission electron microscopy. We also observed the enriched pathways that are involved with platelet activation in RNA sequencing of platelets. MM cell lines were used to assess the effect of platelets on MM cell proliferation in vitro and their engraftment in vivo. RNA sequencing of MM cell lines was performed to explore molecular mechanisms underlying MM cell\u2013platelet interaction and a CRISPR\/Cas9 knockout approach was used for validation.<\/jats:p>\n                  <jats:p>Results: Platelets from MM patients were highly activated with disease progression. RNA sequencing of platelets revealed that genes involved in platelets were enriched in patients with smoldering MM (SMM) or MM. Platelets promoted MM cell proliferation in vitro and contributed to tumor engraftment in bone marrow in vivo. RNA sequencing revealed that IL-1\u03b2 was upregulated in MM cell lines co-cultured with platelets, whereas IL-1\u03b2 knockout in MM cell lines abrogated the effects of platelets on MM cell proliferation and engraftment in vivo.<\/jats:p>\n                  <jats:p>Conclusions: Platelets from MM patients were highly activated with disease progression. IL-1\u03b2 is critical to platelet-mediated MM progression and might be a potential target for MM treatment. Clin Cancer Res; 24(10); 2430\u20139. \u00a92018 AACR.<\/jats:p>","DOI":"10.1158\/1078-0432.ccr-17-2003","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T12:15:18Z","timestamp":1518178518000},"page":"2430-2439","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Platelets Enhance Multiple Myeloma Progression via IL-1\u03b2 Upregulation"],"prefix":"10.1158","volume":"24","author":[{"given":"Satoshi","family":"Takagi","sequence":"first","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokichi","family":"Tsukamoto","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihye","family":"Park","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E.","family":"Johnson","sequence":"additional","affiliation":[{"name":"2Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawara","family":"Kawano","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Moschetta","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Jen","family":"Liu","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Mishima","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsutoshi","family":"Kokubun","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salomon","family":"Manier","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karma Z.","family":"Salem","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Huynh","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Sacco","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."},{"name":"3Clinical Research Development and Phase I Unit; CREA Laboratory, ASST Spedali Civili di Brescia, Brescia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi","family":"Forward","sequence":"additional","affiliation":[{"name":"2Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo M.","family":"Roccaro","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."},{"name":"3Clinical Research Development and Phase I Unit; CREA Laboratory, ASST Spedali Civili di Brescia, Brescia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth M.","family":"Battinelli","sequence":"additional","affiliation":[{"name":"2Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene M.","family":"Ghobrial","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2018,5,14]]},"reference":[{"key":"2022061100501713600_bib1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"key":"2022061100501713600_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4137\/CGM.S11285","article-title":"Regulation of tumor growth and metastasis: the role of tumor microenvironment","volume":"7","author":"Goubran","year":"2014","journal-title":"Cancer Growth Metast"},{"key":"2022061100501713600_bib3","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1182\/blood-2014-08-531582","article-title":"Platelets at the interface of thrombosis, inflammation, and cancer","volume":"126","author":"Franco","year":"2015","journal-title":"Blood"},{"key":"2022061100501713600_bib4","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/ijc.27441","article-title":"Tumor-platelet interaction in solid tumors","volume":"130","author":"Buergy","year":"2012","journal-title":"Int J Cancer"},{"key":"2022061100501713600_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jb\/mvs108","article-title":"The impact of Aggrus\/podoplanin on platelet aggregation and tumour metastasis","volume":"152","author":"Fujita","year":"2012","journal-title":"J Biochem"},{"key":"2022061100501713600_bib6","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"key":"2022061100501713600_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2010.04131.x","article-title":"The platelet contribution to cancer progression","volume":"9","author":"Bambace","year":"2011","journal-title":"J Thrombosis Haemost"},{"key":"2022061100501713600_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"2022061100501713600_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ajh.21732","article-title":"Normal ranges of angiogenesis regulatory proteins in human platelets","volume":"85","author":"Peterson","year":"2010","journal-title":"Am J Hematol"},{"key":"2022061100501713600_bib10","doi-asserted-by":"crossref","first-page":"e73609","DOI":"10.1371\/journal.pone.0073609","article-title":"Platelets promote tumor growth and metastasis via direct interaction between Aggrus\/podoplanin and CLEC-2","volume":"8","author":"Takagi","year":"2013","journal-title":"PloS One"},{"key":"2022061100501713600_bib11","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1158\/2159-8290.CD-12-0216","article-title":"Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells","volume":"2","author":"Kuznetsov","year":"2012","journal-title":"Cancer Discov"},{"key":"2022061100501713600_bib12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","article-title":"Paraneoplastic thrombocytosis in ovarian cancer","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"2022061100501713600_bib13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nnano.2015.342","article-title":"Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery","volume":"11","author":"Matsumoto","year":"2016","journal-title":"Nat Nanotechnol"},{"key":"2022061100501713600_bib14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbamcr.2015.07.008","article-title":"The role of platelets in the tumor microenvironment: from solid tumors to leukemia","volume":"1863","author":"Yan","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"2022061100501713600_bib15","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"key":"2022061100501713600_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"2022061100501713600_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrc746","article-title":"Multiple myeloma: evolving genetic events and host interactions","volume":"2","author":"Kuehl","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"2022061100501713600_bib18","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"key":"2022061100501713600_bib19","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"key":"2022061100501713600_bib20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/imr.12233","article-title":"Targeting the bone marrow microenvironment in multiple myeloma","volume":"263","author":"Kawano","year":"2015","journal-title":"Immunol Rev"},{"key":"2022061100501713600_bib21","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2014-11-568881","article-title":"Pathogenesis beyond the cancer clone(s) in multiple myeloma","volume":"125","author":"Bianchi","year":"2015","journal-title":"Blood"},{"key":"2022061100501713600_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science (New York, NY)"},{"key":"2022061100501713600_bib23","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood.V96.7.2520","article-title":"Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice","volume":"96","author":"Nieswandt","year":"2000","journal-title":"Blood"},{"key":"2022061100501713600_bib24","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/leu.2016.296","article-title":"The LIN28B\/let-7 axis is a novel therapeutic pathway in multiple myeloma","volume":"31","author":"Manier","year":"2017","journal-title":"Leukemia"},{"key":"2022061100501713600_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"2022061100501713600_bib26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2022061100501713600_bib27","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Nat Acad Sci U S A"},{"key":"2022061100501713600_bib28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"2022061100501713600_bib29","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1182\/blood-2009-10-247296","article-title":"Deadly allies: the fatal interplay between platelets and metastasizing cancer cells","volume":"115","author":"Erpenbeck","year":"2010","journal-title":"Blood"},{"key":"2022061100501713600_bib30","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S0049-3848(07)70137-8","article-title":"Bleeding and thrombosis in acute leukemia: what does the future of therapy look like?","volume":"120","author":"Rickles","year":"2007","journal-title":"Thrombosis Res"},{"key":"2022061100501713600_bib31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2010.04131.x","article-title":"The platelet contribution to cancer progression","volume":"9","author":"Bambace","year":"2011","journal-title":"J Thromb Haemost Feb"},{"key":"2022061100501713600_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"2022061100501713600_bib33","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/01.RES.0000021398.28936.1D","article-title":"Nonremodeling properties of matrix metalloproteinases: the platelet connection","volume":"90","author":"Jurasz","year":"2002","journal-title":"Circ Res"},{"key":"2022061100501713600_bib34","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1365-2141.1994.tb06736.x","article-title":"Human melanoma cell lines differ in their capacity to release ADP and aggregate platelets","volume":"87","author":"Boukerche","year":"1994","journal-title":"Br J Haematol"},{"key":"2022061100501713600_bib35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-0038-1661558","article-title":"Platelet activation induced by a human neuroblastoma tumor cell line is reduced by prior administration of ticlopidine","volume":"55","author":"Bastida","year":"1986","journal-title":"Thromb Haemost"},{"key":"2022061100501713600_bib36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00047657","article-title":"Role of plasma, platelets, and endothelial cells in tumor metastasis","volume":"3","author":"Gasic","year":"1984","journal-title":"Cancer Metast Rev"},{"key":"2022061100501713600_bib37","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.1073\/pnas.2234372100","article-title":"Platelet and osteoclast beta3 integrins are critical for bone metastasis","volume":"100","author":"Bakewell","year":"2003","journal-title":"Proc Nat Acad Sci U S A"},{"key":"2022061100501713600_bib38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood-2004-02-0434","article-title":"Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis","volume":"104","author":"Camerer","year":"2004","journal-title":"Blood"},{"key":"2022061100501713600_bib39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1073\/pnas.61.1.46","article-title":"Antimetastatic effects associated with platelet reduction","volume":"61","author":"Gasic","year":"1968","journal-title":"Proc Nat Acad Sci U S A"},{"key":"2022061100501713600_bib40","doi-asserted-by":"crossref","first-page":"9325","DOI":"10.1073\/pnas.95.16.9325","article-title":"P-selectin deficiency attenuates tumor growth and metastasis","volume":"95","author":"Kim","year":"1998","journal-title":"Proc Nat Acad Sci U S A"},{"key":"2022061100501713600_bib41","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1182\/blood.V93.1.300","article-title":"Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma","volume":"93","author":"Lacy","year":"1999","journal-title":"Blood"},{"key":"2022061100501713600_bib42","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1046\/j.1365-2141.1998.01101.x","article-title":"Interleukin-1 in multiple myeloma: producer cells and their role in the control of IL-6 production","volume":"103","author":"Costes","year":"1998","journal-title":"Br J Haematol"},{"key":"2022061100501713600_bib43","first-page":"868","article-title":"Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors","volume":"24","author":"Torcia","year":"1996","journal-title":"Exp Hematol"},{"key":"2022061100501713600_bib44","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1084\/jem.173.3.599","article-title":"Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis","volume":"173","author":"Miyake","year":"1991","journal-title":"J Exp Med"},{"key":"2022061100501713600_bib45","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/blood.V75.3.589.589","article-title":"Hematopoietic progenitor cell expression of the H-CAM (CD44) homing-associated adhesion molecule","volume":"75","author":"Lewinsohn","year":"1990","journal-title":"Blood"},{"key":"2022061100501713600_bib46","doi-asserted-by":"crossref","first-page":"148","DOI":"10.7326\/0003-4819-159-2-201307160-00013","article-title":"Alternate-day, low-dose aspirin and cancer risk","volume":"159","author":"Rothwell","year":"2013","journal-title":"Ann Int Med"},{"key":"2022061100501713600_bib47","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"2022061100501713600_bib48","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/1471-2407-14-391","article-title":"Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in Sweden","volume":"14","author":"Holmes","year":"2014","journal-title":"BMC Cancer"},{"key":"2022061100501713600_bib49","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ijc.2910110322","article-title":"Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease","volume":"11","author":"Gasic","year":"1973","journal-title":"Int J Cancer"},{"key":"2022061100501713600_bib50","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jamaoncol.2015.6396","article-title":"Population-wide impact of long-term use of aspirin and the risk for cancer","volume":"2","author":"Cao","year":"2016","journal-title":"JAMA Oncol"},{"key":"2022061100501713600_bib51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1158\/1940-6207.CAPR-13-0224","article-title":"Regular aspirin use and risk of multiple myeloma: a prospective analysis in the health professionals follow-up study and nurses' health study","volume":"7","author":"Birmann","year":"2014","journal-title":"Cancer Prev Res"}],"container-title":["Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/24\/10\/2430\/2044033\/2430.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/24\/10\/2430\/2044033\/2430.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T08:05:24Z","timestamp":1654934724000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article\/24\/10\/2430\/80760\/Platelets-Enhance-Multiple-Myeloma-Progression-via"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,14]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,5,14]]},"published-print":{"date-parts":[[2018,5,15]]}},"URL":"https:\/\/doi.org\/10.1158\/1078-0432.ccr-17-2003","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1078-0432.22465200.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22465206","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22465188","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22465209","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22465197.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22465209.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.c.6525945.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22465191.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22465191","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22465194","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22465203.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22465188.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22465206.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.c.6525945","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22465197","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22465194.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22465200","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22465203","asserted-by":"object"}]},"ISSN":["1078-0432","1557-3265"],"issn-type":[{"value":"1078-0432","type":"print"},{"value":"1557-3265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,14]]}}}